Paul Damon & Associates, Inc. Johnson & Johnson Transaction History
Paul Damon & Associates, Inc.
- $191 Billion
- Q2 2025
A detailed history of Paul Damon & Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Paul Damon & Associates, Inc. holds 2,862 shares of JNJ stock, worth $490,918. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,862Holding current value
$490,918% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding JNJ
# of Institutions
4,626Shares Held
1.72BCall Options Held
25MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA234MShares$40.1 Billion0.72% of portfolio
-
Black Rock Inc. New York, NY198MShares$34 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$22.9 Billion0.94% of portfolio
-
Geode Capital Management, LLC Boston, MA60.6MShares$10.4 Billion0.67% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$9.27 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $448B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...